307 related articles for article (PubMed ID: 30206203)
41. Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype.
Kamath-Loeb AS; Zavala-van Rankin DG; Flores-Morales J; Emond MJ; Sidorova JM; Carnevale A; Cárdenas-Cortés MD; Norwood TH; Monnat RJ; Loeb LA; Mercado-Celis GE
Sci Rep; 2017 Mar; 7():44081. PubMed ID: 28276523
[TBL] [Abstract][Full Text] [Related]
42. ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells.
Marabitti V; Lillo G; Malacaria E; Palermo V; Sanchez M; Pichierri P; Franchitto A
Nucleic Acids Res; 2019 Apr; 47(7):3485-3502. PubMed ID: 30657978
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
44. A novel mutation of the WRN gene in a Chinese patient with Werner syndrome.
Zhao N; Hao F; Qu T; Zuo YG; Wang BX
Clin Exp Dermatol; 2008 May; 33(3):278-81. PubMed ID: 18205852
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
46. WRN at telomeres: implications for aging and cancer.
Multani AS; Chang S
J Cell Sci; 2007 Mar; 120(Pt 5):713-21. PubMed ID: 17314245
[TBL] [Abstract][Full Text] [Related]
47. Hydrogen sulfide restores a normal morphological phenotype in Werner syndrome fibroblasts, attenuates oxidative damage and modulates mTOR pathway.
Talaei F; van Praag VM; Henning RH
Pharmacol Res; 2013 Aug; 74():34-44. PubMed ID: 23702336
[TBL] [Abstract][Full Text] [Related]
48. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
[TBL] [Abstract][Full Text] [Related]
49. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest.
Von Kobbe C; May A; Grandori C; Bohr VA
FASEB J; 2004 Dec; 18(15):1970-2. PubMed ID: 15459124
[TBL] [Abstract][Full Text] [Related]
50. WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex.
Shiratori M; Suzuki T; Itoh C; Goto M; Furuichi Y; Matsumoto T
Oncogene; 2002 Apr; 21(16):2447-54. PubMed ID: 11971179
[TBL] [Abstract][Full Text] [Related]
51. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors.
Oshima J; Campisi J; Tannock TC; Martin GM
J Cell Physiol; 1995 Feb; 162(2):277-83. PubMed ID: 7822435
[TBL] [Abstract][Full Text] [Related]
52. Efficient RNA-Based Reprogramming of Disease-Associated Primary Human Fibroblasts into Induced Pluripotent Stem Cells.
McGrath PS; McGarvey SS; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2117():271-284. PubMed ID: 31960386
[TBL] [Abstract][Full Text] [Related]
53. Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases.
Lebel M; Monnat RJ
Ageing Res Rev; 2018 Jan; 41():82-97. PubMed ID: 29146545
[TBL] [Abstract][Full Text] [Related]
54. Development of Individualized Induced Pluripotent Stem Cells From Fibroblasts of Keloid Lesions in Patients.
Zhang YX; Liu LP; Li M; Huang JL; Xu H; Chen XD; Zhu WY; Cai YP; Guo NN; Chen ZQ; Zheng YW; Li YM
Transplant Proc; 2018 Nov; 50(9):2868-2871. PubMed ID: 30401414
[TBL] [Abstract][Full Text] [Related]
55. The transcriptional response to distinct growth factors is impaired in Werner syndrome cells.
Lutomska A; Lebedev A; Scharffetter-Kochanek K; Iben S
Exp Gerontol; 2008 Sep; 43(9):820-6. PubMed ID: 18625297
[TBL] [Abstract][Full Text] [Related]
56. The Werner syndrome protein contributes to induction of p53 by DNA damage.
Blander G; Zalle N; Leal JF; Bar-Or RL; Yu CE; Oren M
FASEB J; 2000 Nov; 14(14):2138-40. PubMed ID: 11023999
[TBL] [Abstract][Full Text] [Related]
57. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle.
Pichierri P; Rosselli F; Franchitto A
Oncogene; 2003 Mar; 22(10):1491-500. PubMed ID: 12629512
[TBL] [Abstract][Full Text] [Related]
58. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase.
Johnson FB; Marciniak RA; McVey M; Stewart SA; Hahn WC; Guarente L
EMBO J; 2001 Feb; 20(4):905-13. PubMed ID: 11179234
[TBL] [Abstract][Full Text] [Related]
59. Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length.
Gatinois V; Desprat R; Becker F; Pichard L; Bernex F; Corsini C; Pellestor F; Lemaitre JM
Stem Cell Res; 2019 Aug; 39():101515. PubMed ID: 31404747
[TBL] [Abstract][Full Text] [Related]
60. The G2-phase decatenation checkpoint is defective in Werner syndrome cells.
Franchitto A; Oshima J; Pichierri P
Cancer Res; 2003 Jun; 63(12):3289-95. PubMed ID: 12810661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
